Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania

AIDS Research and Human Retroviruses

Volumn 27, Issue 4, 2011, Pages 377-382

  Mosha, F ^a   Urassa, W ^b   Aboud, S ^b   Lyamuya, E ^b   Sandstrom, E ^c   Bredell, H ^d   Williamson, C ^d  

^a MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; STAVUDINE;

ADOLESCENT; ADULT; ARTICLE; CROSS RESISTANCE; CROSS-SECTIONAL STUDY; DRUG TREATMENT FAILURE; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; TANZANIA; VIRUS MUTATION; VIRUS RECOMBINANT;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HIV; HIV INFECTIONS; HUMANS; MALE; MUTATION, MISSENSE; PREVALENCE; RECOMBINATION, GENETIC; TANZANIA; YOUNG ADULT;

EID: 79953763329     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0113     Document Type: Article

References (26)

1. Tanzania Commission for AIDS (TACAIDS), Dar es Salaam, Tanzania. Tanzania HIV/AIDS and Malaria Indicator Survey 2007-08, 2008:31-32.
2. The United Republic of Tanzania,Ministry of Health: National Guidelines for the Clinical Management of HIV and AIDS, National AIDS Control Programme (NACP) 2005;2:89-95.
3. Machado ES, Lambert JS, Afonso AO, et al.: Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil. An Acad Bras Cienc 2004;76(4):727-741. (Pubitemid 40019646)
4. Kresge JK: Two New AIDS Vaccine Trials Initiated in Africa. IAVI report 2006; 10(6). Available at http://www.iavi.org.
5. Urassa WK, Mbena EM, Swai AB, Gaines H, Mhalu FS, and Biberfeld G: Lymphocyte subset enumeration in HIV sero-negative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: Determination of reference values in males and females and comparison of two flow cytometric methods. J Immunol Methods 2003;277(1-2):65-74. (Pubitemid 36694374)
6. Vandamme A, Witvrouw M, Pannecouque C, Balzarini J, Van Laethem K, Schmit J, Desmyter J, and De Clercq E: Evaluating clinical isolates for their phenotypic and genotypic resistance against anti-HIV drugs. In: Antiviral Methods and Protocols (Vol. 24, pp. 223-258). Springer, New York, 1999.
7. Bredell H, Martin D, Van Harmelen J, et al.: HIV type 1 subtype C gag and nef diversity in Southern Africa. AIDS Res Hum Retroviruses 2007;23(3):477-481. (Pubitemid 46608569)
8. Delwart E, Herring B, Rodrigo A, et al.: Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. PCR Methods Appl 1995;4(5):S202-S216.
9. Johnson VA, Brun-Vézine F, Clotet B, et al.: Special contribution update of the drug resistance mutations in HIV-1. International AIDS Society-USA. Top HIV Med 2009; 5:17.
10. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL-X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25(24):4876-4882. (Pubitemid 28022245)
11. Felsenstein J: Estimating effective population size from samples of sequences: A bootstrap Monte Carlo integration method. Genet Res 1992;60(3):209-220.
12. Tamura K, Dudley J, Nei M, and Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-1599. http://www.kumarlab.net/publications. (Pubitemid 47236692)
13. HIV Drug Resistance Database: A curated public database designed to represent, store and analyze the divergent forms of data underlying HIV drug resistance 2005. Available at http://hivdb.stanford.edu.
14. REGA HIV-1 Automated Subtyping Tool - Version 1.0. Katholieke Universiteit Leuven 2005. Available at www.jose.med.kuleuven.be/subtypetool/ html/subtyping.html, 2008.
15. Pond SL: Genetic Algorithm Subtype Prediction (GASPREAD). 2006-2008.
16. Virus Genotyping Tools, HIV Bioinformatics BioAfrica. Available at http://www.bioafrica.net/subtypetool/html/.
17. McInerney J: Recombination-detection-program 1997.
18. HIV databases 2005. Available at http://hiv-web.lanl.gov.
19. Morris M, Handcock MS, Miller WC, et al.: Prevalence of HIV infection among young adults in the United States: Results from the Add Health Study. Am J Public Health 2006;96(6):1091-1097. (Pubitemid 43825280)
20. Robb ML, McCutchan FE, Carr JK, et al.: Support of HIV-1 vaccine development in East Africa: Sequencing of 96 fullgenome sequences from Uganda, Kenya, and Tanzania. AIDS Vaccine 2001; abstract no. 25.
21. Lyamuya E, Olausson-Hansson E, Albert J, Mhalu F, and Biberfeld G: Evaluation of a prototype Amplicor PCR assay for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults infected with HIV-1 subtypes A, C and D. J Clin Virol 2000;17(1):57-63. (Pubitemid 30256293)
22. Kiwelu IE, Chaplin B, Sam N, Nkya WM, Shao J, Kapiga S, and Essex M: HIV type 1 subtypes among bar and hotel workers in Moshi, Tanzania. AIDS Res Hum Retroviruses 2003;19(1):57-64. (Pubitemid 36398744)
23. Arroyo MA, Hoelscher M, Sanders-Buell E, et al.: HIV type I subtypes among blood donors in the Mbeya region of Southwest Tanzania. AIDS Res Hum Retroviruses 2004;20: 895-901. (Pubitemid 39121210)
24. Nyombi B, Hansen C, Kristiansen K, Bjune G, and Müller F: Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania. AIDS Res Ther 2008;5:13.
25. Somi GR, Kibuka T, Diallo K, et al.: Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. Antivir Ther 2008;13(Suppl 2):77-82. (Pubitemid 352019092)
26. Shekelle P, Maglione M, Geotz MB, Wagner G, Wang Z, Hilton L, Carter J, Chen S, Tringle C, Mojica W, and Newberry S: Antiretroviral (ARV) drug resistance in the developing world. Evid Rep Technol Assess (Full Rep) 2007; (156):1-74.